AUTH/2371/11/10: Ex-employee v Astellas Pharma (Promotional practices) – No breach | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2371/11/10
Parties	Ex-employee v Astellas Pharma Ltd
Issue	Promotional practices (alleged inducements/switching, meeting communications, representative conduct, Zineryt 90ml promotion)
Applicable Code year	2008
Complaint received	22 November 2010
Case completed	11 March 2011
Appeal	No appeal
Clauses considered	2, 9.1, 12.1, 14, 15.3, 18.1, 18.4
Outcome	No breach
Products mentioned	Flomaxtra (tamsulosin), Zineryt (30ml and 90ml)
Meeting referenced	25 November 2009 (urology-related meeting; communications included NHS trust headed paper letter signed by consultants; sponsorship declaration disputed between versions)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A former employee complained about Astellas’ promotional practices, alleging multiple serious breaches that allegedly brought the industry into disrepute and wasted NHS funds.
Allegations included: inducements/excessive payments to switch patients from generics to Astellas brands (including Flomaxtra), “blanket switches” prejudicing patient safety, and misleading/disguised promotional meetings presented as “NHS meetings” (use of NHS logos, “mandatory” attendance messaging, branded “goody bags”, and attendance certificates used as “access tools”).
Further allegation: pressure to encourage excessive prescribing of Zineryt 90ml (vs 30ml), causing waste due to limited shelf life.
Astellas denied the allegations and provided meeting materials and other documentation; the Panel noted the case largely came down to one person’s word against another and the complainant provided very little supporting evidence.

⚖️

⌄

No breach of the Code was ruled.
The Panel found insufficient evidence of inducements, disguised promotion, subterfuge by representatives, or inappropriate promotion of Zineryt 90ml.

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access